Mazyar Shadman, MD,MPH

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Mustang Bio
    Topic:
    Ad Board
    Date added:
    12/27/2022
    Date updated:
    11/03/2023
    Relationship end date:
    12/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BMS
    Topic:
    Ad Board
    Date added:
    12/27/2022
    Date updated:
    11/03/2023
    Relationship end date:
    12/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pharmacyclics
    Topic:
    Ad Board
    Date added:
    12/27/2022
    Date updated:
    11/03/2023
    Relationship end date:
    12/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genentech
    Topic:
    Ad Board
    Date added:
    12/27/2022
    Date updated:
    11/03/2023
    Relationship end date:
    12/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AbbVie
    Topic:
    Ad Board
    Date added:
    12/27/2022
    Date updated:
    11/03/2023
    Relationship end date:
    12/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    TG Therapeutics
    Topic:
    Ad Board
    Date added:
    12/27/2022
    Date updated:
    11/03/2023
    Relationship end date:
    12/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BeiGene
    Topic:
    Ad Board
    Date added:
    12/27/2022
    Date updated:
    11/03/2023
    Relationship end date:
    12/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    AstraZeneca
    Topic:
    Ad Board
    Date added:
    12/27/2022
    Date updated:
    11/03/2023
    Relationship end date:
    12/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Genmab
    Topic:
    Ad Board
    Date added:
    12/27/2022
    Date updated:
    11/03/2023
    Relationship end date:
    12/27/2022
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    MorphoSys/Incyte
    Topic:
    Ad Board
    Date added:
    12/27/2022
    Date updated:
    11/03/2023
    Relationship end date:
    12/27/2022

Pages

Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice